Last reviewed · How we verify
SOTB07
At a glance
| Generic name | SOTB07 |
|---|---|
| Sponsor | SK Chemicals Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients (PHASE3)
- Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SOTB07 CI brief — competitive landscape report
- SOTB07 updates RSS · CI watch RSS
- SK Chemicals Co., Ltd. portfolio CI